Adherium Ltd. (AU:ADR) has released an update.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Adherium Limited reported a decrease in revenue by 73.7% and a slight increase in losses compared to the previous year. The company is focused on expanding its remote patient monitoring services in the U.S. healthcare market, aiming for cash flow positivity. Their new strategy involves partnering with U.S. health entities, enhancing patient adherence and proper inhaler use through remote monitoring to improve the quality of life for asthma sufferers.
For further insights into AU:ADR stock, check out TipRanks’ Stock Analysis page.